Aurobindo Pharma gets nod to acquire 51% stake in GLS Pharma

20 Jun 2022 Evaluate

Aurobindo Pharma has received an approval for the acquisition of 51% equity shares in GLS Pharma, operating in oncology business and having manufacturing facility in Hyderabad for a total consideration of Rs 28.05 crore. This acquisition is undertaken to expand the foothold of the company in Oncology business in the domestic market and inorganic addition to capacity and revenues in oncology business. The completion of the share transfer is estimated before July 31, 2022. The Board of Directors of the Company at its meeting held on June 17, 2022, has approved the same.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1401.10 5.10 (0.37%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.